SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Amgen Inc. (AMGN) -- Ignore unavailable to you. Want to Upgrade?


To: Paul Senior who wrote (1885)8/13/2014 7:46:07 PM
From: Mike K  Read Replies (1) | Respond to of 1906
 
The Kyprolis trial was for a single agent. Kyprolis was never really considered to be a single agent drug
instead in combination with other myeloma drugs. I'm currently in a trial with Kyprolis & Pomalyst (Celgene) and it's working really well.



To: Paul Senior who wrote (1885)8/14/2014 11:16:35 AM
From: mopgcw  Respond to of 1906
 
hope you were able to add after hours. nice move this morning...